RIPE-KG · Version 1.1.0 · Resource

ripekg:publication-details/RIPEA237F9DCBC31EFBBD

https://w3id.org/ripe/ripe-kg/publication-details/RIPEA237F9DCBC31EFBBD

Subject	Predicate	Object
`ripekg:evaluation/RIPEA237F9DCBC31EFBBD`	`prov:used`	`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`prism:eIssn`	1756-1833
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`prism:publicationDate`	2025-04-15
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`prism:publicationName`	BMJ
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`dcterms:publisher`	`ripekg:publisher/RIPEP9377BEC70BC5BE0F`BMJ
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`dcterms:title`	Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`rdf:type`	`http://purl.org/spar/fabio/BibliographicMetadata`
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`rdf:type`	`rdfs:Resource`
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`rdf:type`	`owl:Thing`
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`rdf:type`	`ripe:IntegrityAssessmentEvidence`Integrity assessment evidence
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`rdf:type`	`ripe:PublicationDetails`Publication details
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`rdf:type`	`tido:Evidence`
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`prov:wasGeneratedBy`	`ripekg:evidence-aggregation/RIPEA237F9DCBC31EFBBD`
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`prov:wasMemberOf`	`ripekg:research-integrity-assessment/RIPEA237F9DCBC31EFBBD`
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`ripe:concerns`	`ripekg:work/10.1136%2Fbmj-2024-081557`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`tido:supports`	`ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1`
`ripekg:publication-details/RIPEA237F9DCBC31EFBBD`Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial	`tido:supports`	`ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-inspectai-1-1`